Lv41
510 积分 2026-04-21 加入
8-PUB: High-Dose Crisugabalin Significantly Improving the Pain Symptoms in Patients with Diabetic Peripheral Neuropathic Pain (DPNP)
17天前
已完结
Discovery of HighlyPotent G Protein-Biased BisamideKappa Opioid Receptor Agonists
19天前
已完结
κ-阿片受体选择性激动剂类镇痛药物研究进展
19天前
已完结
Sibeprenlimab (Voyxact) for primary immunoglobulin A nephropathy
1个月前
已关闭
Sibeprenlimab (Voyxact) for primary immunoglobulin A nephropathy
1个月前
已关闭
Cholestatic Pruritus: A Review of Pathophysiology, Clinical Manifestations, and Therapeutic Landscape
1个月前
已完结
Real-world effectiveness and tolerability of difelikefalin over 12 months for hemodialysis-associated pruritus
1个月前
已完结
Incretin-based therapies and all-cause mortality and progression to multiple myeloma in patients with MGUS and type 2 diabetes: A real-world cohort study
2个月前
已关闭
Difelikefalin-associated adverse drug event signals: a real-world pharmacovigilance study from the FAERS database
2个月前
已完结
Examining the association of dipeptidyl peptidase-4 inhibitors with autoimmune blistering disorders in the U.S. Military veterans
3个月前
已完结
皖公网安备34019202002308
